EP Patent

EP3103441B1 — Diclofenac formulations and methods of use

Assigned to APR Applied Pharma Research SA · Expires 2022-03-16 · 4y expired

What this patent protects

Patent listed against diclofenac-potassium.

Drugs covered by this patent

diclofenac-potassium (DICLOFENAC POTASSIUM)

Patent Metadata

Patent number: EP3103441B1
Jurisdiction: EP
Classification: —
Expires: 2022-03-16
Drug substance claim: No
Drug product claim: No
Assignee: APR Applied Pharma Research SA
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.